James E. Blaugrund

James Blaugrund practices at UPMC Presbyterian in Pittsburgh, Pennsylvania, part of University of Pittsburgh Medical Center.

James Blaugrund's NPI, 1831162312, was assigned on February 7, 2006. James Blaugrund graduated from Yale University School of Medicine in 1992. James Blaugrund holds Pennsylvania license MD065380L.

James Blaugrund's primary practice is UPMC Presbyterian, at 200 Lothrop Street, Pittsburgh, PA 15213 in Allegheny County. The practice phone is (412) 647-2345.

James Blaugrund's primary practice is UPMC Presbyterian in Pittsburgh, Pennsylvania, part of University of Pittsburgh Medical Center. James Blaugrund is also affiliated with Select Specialty Hospital - Pittsburgh / UPMC. The medical group on file is Stull, Jarvis, and Spinola Internal Medicine Associates-UPMC. Dmand AI also links James Blaugrund to 6 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where James Blaugrund practices, 10 sites in all. Vendor and product names are available with a free account.

Otolaryngology is James Blaugrund's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. James Blaugrund is licensed in Pennsylvania.

CMS data shows 2,367 Medicare services from James Blaugrund across 14 procedure codes in 2024, for 704 Medicare patients. Medicare paid $103,690 for them. Every service was in an office.

CMS counts 704 Medicare patients who saw James Blaugrund in 2024. The largest group is 65 to 74, with 344 patients. 75% of them have high cholesterol, and 69% have high blood pressure. 5% are also on Medicaid. Their average risk score is 1.10, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts James Blaugrund's median patient age at 67, with 58% women.

In 2024, James Blaugrund wrote 1,762 Medicare Part D claims for 631 patients. 99% of them were for generic drugs. CMS names the drug for 1,638 of them, across 21 drugs with 11 or more claims each, at $22,816 in total drug cost. In 2023, CMS named 1,692 claims across 27 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for James Blaugrund for performance year 2024, reported as part of a group. James Blaugrund accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists James Blaugrund as offering telehealth. CMS counts 17 procedures of spinal fusion by James Blaugrund, more than 34% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 1 general payment to James Blaugrund from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Medtronic, Inc. paid the most, $31.

James Blaugrund graduated from Yale University School of Medicine in 1992.